Seed · Biotech · Cambridge, United Kingdom · Founded 2022 · 11–50 employees
Coherence Neuro, originally founded as Opto Biosystems, is a deep-tech medical technology startup developing minimally invasive, wireless, implantable neural interfaces to manage aggressive cancers like glioblastoma. Its flagship technology, including the coin-sized SOMA-1 implant and the CIPHER cortical probe system, reads the brain's electrical signals and delivers targeted bioelectronic stimulation to disrupt tumor growth in real time. The company secured a $10 million Seed funding round co-led by Topology Ventures and Artesian in November 2025 to advance its neural interface platform. It previously won the Wolfson Enterprise Competition in 2022 and participated in the Cancer Tech Accelerator program backed by Cancer Research UK, Roche, and the Medical Research Council.